Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yihuohuatan Decoction is a Traditional Chinese Medicine (TCM) herbal formulation developed for the treatment of stable chronic obstructive pulmonary disease (COPD). The prescription is based on the TCM theory of "warming the kidney to transform phlegm" (Yihuo Huatan), targeting the underlying pathogenesis of lung and kidney deficiency often seen in chronic respiratory ailments. It is primarily being evaluated in clinical trials led by the West China Hospital of Sichuan University to assess its impact on lung function, symptom management, and systemic inflammation in patients with stable COPD.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yihuohuatan Decoction.